AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | -33.3% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | +33.3% | 4,000 | 0.0% | 0.00% | +33.3% |
| Q3 2016 | $3,000 | -40.0% | 4,000 | 0.0% | 0.00% | -40.0% |
| Q2 2016 | $5,000 | -44.4% | 4,000 | 0.0% | 0.01% | -44.4% |
| Q1 2016 | $9,000 | -35.7% | 4,000 | 0.0% | 0.01% | -30.8% |
| Q4 2015 | $14,000 | +16.7% | 4,000 | 0.0% | 0.01% | +18.2% |
| Q3 2015 | $12,000 | +33.3% | 4,000 | 0.0% | 0.01% | +37.5% |
| Q2 2015 | $9,000 | -70.0% | 4,000 | 0.0% | 0.01% | -66.7% |
| Q1 2015 | $30,000 | +114.3% | 4,000 | 0.0% | 0.02% | +140.0% |
| Q4 2014 | $14,000 | 0.0% | 4,000 | 0.0% | 0.01% | -9.1% |
| Q3 2014 | $14,000 | +133.3% | 4,000 | +300.0% | 0.01% | +120.0% |
| Q1 2014 | $6,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |